Regulation of melanoma malignancy by the RP11-705C15.3/miR-145-5p/NRAS/MAPK signaling axis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-5500
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Regulation of melanoma malignancy by the RP11-705C15.3/miR-145-5p/NRAS/MAPK signaling axis ; day:14 ; month:12 ; year:2020 ; pages:1-15
Cancer gene therapy ; (14.12.2020), 1-15
- Urheber
-
Chen, Xiang-jun
Liu, Sha
Han, Dong-mei
Han, De-zhi
Sun, Wei-jing
Zhao, Xiao-chun
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41417-020-00274-5
- URN
-
urn:nbn:de:101:1-2021012118060564418496
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:22 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Chen, Xiang-jun
- Liu, Sha
- Han, Dong-mei
- Han, De-zhi
- Sun, Wei-jing
- Zhao, Xiao-chun
- SpringerLink (Online service)
Ähnliche Objekte (12)
The lincRNA MIRAT binds to IQGAP1 and modulates the MAPK pathway in NRAS mutant melanoma
MEK targeting in N-RAS mutated metastatic melanoma
STAT3 – the switch of melanoma-associated NRAS mutations
Vulvar melanoma: Rare gynaecological malignancy
Vulvar melanoma: Rare gynaecological malignancy
Combinatorial effects of azacitidine and trametinib on NRAS‐mutated melanoma
Combination of pan-RAF and MEK inhibitors in NRAS mutant melanoma
Pharmacological targeting of casein kinase 1δ suppresses oncogenic NRAS-driven melanoma
Exploiting TERT dependency as a therapeutic strategy for NRAS-mutant melanoma
Hepatic passaging of NRAS-mutant melanoma influences adhesive properties and metastatic pattern
Heterogeneous distribution of BRAF/NRAS mutations among Italian patients with advanced melanoma
A novel combination treatment against melanoma with NRAS mutation and therapy resistance
The lincRNA MIRAT binds to IQGAP1 and modulates the MAPK pathway in NRAS mutant melanoma
MEK targeting in N-RAS mutated metastatic melanoma
STAT3 – the switch of melanoma-associated NRAS mutations
Vulvar melanoma: Rare gynaecological malignancy
Vulvar melanoma: Rare gynaecological malignancy
Combinatorial effects of azacitidine and trametinib on NRAS‐mutated melanoma
Combination of pan-RAF and MEK inhibitors in NRAS mutant melanoma
Pharmacological targeting of casein kinase 1δ suppresses oncogenic NRAS-driven melanoma
Exploiting TERT dependency as a therapeutic strategy for NRAS-mutant melanoma
Hepatic passaging of NRAS-mutant melanoma influences adhesive properties and metastatic pattern
Heterogeneous distribution of BRAF/NRAS mutations among Italian patients with advanced melanoma
A novel combination treatment against melanoma with NRAS mutation and therapy resistance
The lincRNA MIRAT binds to IQGAP1 and modulates the MAPK pathway in NRAS mutant melanoma
MEK targeting in N-RAS mutated metastatic melanoma
STAT3 – the switch of melanoma-associated NRAS mutations
Vulvar melanoma: Rare gynaecological malignancy
Vulvar melanoma: Rare gynaecological malignancy
Combinatorial effects of azacitidine and trametinib on NRAS‐mutated melanoma
Combination of pan-RAF and MEK inhibitors in NRAS mutant melanoma
Pharmacological targeting of casein kinase 1δ suppresses oncogenic NRAS-driven melanoma
Exploiting TERT dependency as a therapeutic strategy for NRAS-mutant melanoma
Hepatic passaging of NRAS-mutant melanoma influences adhesive properties and metastatic pattern
Heterogeneous distribution of BRAF/NRAS mutations among Italian patients with advanced melanoma